Mastoidectomy-tympanoplasty Surgery.
Conditions
Interventions
Intervention 1: Intervention group: In this group, 0.15 mg/kg morphine (Daru Pakhsh Company) and 10 mg triamcinolone (Germany Hexal Company) to 100 mg lidocaine 2% (Aburaihan Tehran) and epinephrine w
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 15 to 65 years Indicated for mastoidectomy-tympanoplasty Satisfaction to participate in the study
Exclusion criteria
Exclusion criteria: Having a history of drug and alcohol addiction Having a history of seizures and mental health problems Having kidney disease Death of the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: Immediately upon entering the recovery and at 2, 8, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: Before induction of anesthesia, immediately after induction of anesthesia and every ten minutes during surgery until the end of surgery. Method of measurement: Monitoring device.;Diastolic blood pressure. Timepoint: Before induction of anesthesia, immediately after induction of anesthesia and every ten minutes during surgery until the end of surgery. Method of measurement: Monitoring device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReihanak Talakoub
Esfahan University of Medical Sciences
Outcome results
None listed